ArticleMolecular therapy. Methods & clinical development2017

Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting.

Victoria M Velazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.